doi:10.3969/j.issn.1673-8640.2015.03.027

Abstract

CLC Number:

R446.1

Figures/Tables 1

References 8

[1]	SU SJ, HUANG LW, PAI LS, et al.Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression[J]. Nutrition, 2005,21(10):994-1002.
[2]	宋伟. 2型糖尿病患者血浆高半胱氨酸、载脂蛋白(a)与视网膜病变的关系探讨——附150例检测报告分析[J]. 新医学, 2009,40(3):180-181.
[3]	林东, 袁璧钗, 黄晓新. 血浆同型半胱氨酸水平与脑梗死的临床相关性研究[J]. 新医学, 2010,10(5):305-306.
[4]	彭乃杰, 李克诚, 夏菲, 等. 血清同型半胱氨酸水平与急性脑梗死的相关性研究[J]. 检验医学, 2013,28(3):257-258
[5]	KEAN RB, SPITSIN SV, MIKHEEVA T, et al.The peroxynitrite scavenger uric acid prevent's inflammatory cell into the central nervous system in experimental allergic encephalomyelitis though maintenance of blood central nervous system barrier intercity[J]. J Immunol, 2000,165(11):6511-6518.
[6]	诸芳芳. 中老年人血清葡萄糖、尿酸、胆固醇、甘油三酯水平分析[J]. 检验医学, 2014,29(4):405-406
[7]	乔曼丽, 吴升平, 王文志, 等. 血脂与卒中[J]. 国际脑血管病杂志, 2006,14(7):515-518.
[8]	蒋兴亮, 周京国, 唐中. 脑梗死患者血浆胆红素和氧化低密度脂蛋白水平变化及意义[J]. 中华急症医学杂志, 2005,14(2):157-160.

组别	例数	Hcy	UA	TG	TC	LDL-C
正常对照组	160	12.76±3.57	301.11±77.07	1.65±1.22	4.65±0.88	2.66±0.92
脑梗死组	160	23.98±6.96^*	310.92±88.93	1.97±1.44	4.38±1.08	2.94±0.80^*

组别	例数	Hcy	UA	TG	TC	LDL-C
正常对照组	160	12.76±3.57	301.11±77.07	1.65±1.22	4.65±0.88	2.66±0.92
脑梗死组	160	23.98±6.96^*	310.92±88.93	1.97±1.44	4.38±1.08	2.94±0.80^*

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 8

Related Articles 15

Recommended Articles

Metrics